Sixth Immunotherapy of Cancer conference (ITOC): advances and perspectives—a meeting report

Immunotherapy has moved to the forefront of cancer treatment, illustrated by the accelerating pace of novel therapy approvals. In this complex environment, scientists rely on cutting edge conferences to stay informed. The Immunotherapy of Cancer (ITOC) conference was established jointly with the Soc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinto, Catarina, Bergmann, Michael, Briukhovetska, Daria, Nuessler, Volkmar, Sznol, Mario, von Bergwelt-Baildon, Michael, Kobold, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Meeting Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057436/
https://www.ncbi.nlm.nih.gov/pubmed/32114499
http://dx.doi.org/10.1136/jitc-2019-000268
Descripción
Sumario:Immunotherapy has moved to the forefront of cancer treatment, illustrated by the accelerating pace of novel therapy approvals. In this complex environment, scientists rely on cutting edge conferences to stay informed. The Immunotherapy of Cancer (ITOC) conference was established jointly with the Society of the Immunotherapy of Cancer to bring the European researchers together. In its sixth edition, the ITOC conference has recently been held in Vienna, Austria.

Ejemplares similares